Discover the detailed record of transactions filed by 구준모, Chief Executive Officer. Officer active across 2 companies, notably 광동제약. Aggregated, 10 filings have been recorded. The latest transaction was filed on 27 February 2026 — Purchase. Regulator: DART (FSS). All data is openly available.
Koo Jun-mo is an Executive Director at Kwangdong Pharmaceutical, where he is responsible for managing operations and the company's strategy. His expertise in the pharmaceutical sector allows him to effectively lead the team and ensure that products meet quality standards. He plays a key role in developing new products and expanding the company.